Biotechnology News

August 15, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended June 30, 2012. Kinneret Savitsky, Ph.D., CEO of BioLineRx, remarked, “During the...

August 15, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Relypsa Inc announced an $80M Series C preferred stock financing to fund late-stage development, submission of an NDA and commercial planning for patiromer (RLY5016), a high capacity potassium binder.

August 15, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals from non-petroleum sources, has been granted a United States Patent for a bio-based adipic acid...

August 15, 2012

SAN FRANCISCO--(BUSINESS WIRE)--The Thiel Foundation announced today three new grants awarded through Breakout Labs. The newest awards focus on solutions at the intersection of biology and advanced technologies.

August 15, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka America Pharmaceutical, Inc. today announced the launch of patient management programs for Sprycel® (dasatinib) patients with a select group of specialty...

August 15, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences announced today that it has initiated a Phase 1/2a clinical study with its lead candidate, GEN-003. GEN-003 is an investigational vaccine designed to stimulate T cell and B cell immune...

August 15, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and...

August 15, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) (“ImmunoCellular” or the “Company”), today announced second quarter results for the period ended June 30, 2012. Highlights of the second quarter and recent weeks...

August 15, 2012

SAN DIEGO--(BUSINESS WIRE)--Epic Sciences, Inc. (“Epic”), a privately held cancer diagnostics company, announced today that it has established collaborations with six pharmaceutical partners employing Epic’s proprietary Circulating Tumor Cell (“...

August 15, 2012

BANGKOK--(BUSINESS WIRE)--Vejthani Hospital offers Sprained Ankle Treatment, the way to relieve your pain at Vejthani Orthopaedic Clinic in Bangkok Thailand.

August 14, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today reported financial results for its second...

August 14, 2012

MINNEAPOLIS--(BUSINESS WIRE)--HEI, Inc. (Pink Sheets: HEII; http://www.heii.com) today announced its financial results for the second quarter of fiscal year 2012, which ended June 30,...

August 14, 2012

WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. today reported its operating results for the three and six months ended June 30, 2012. Vasomedical Announces 48.7% Increase in Revenue for the Second Quarter 2012.

August 14, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology released its financial results for the second quarter of 2012 and provided an update on the development program for its lead drug candidate, neratinib.

August 14, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics Reports Second Quarter 2012 Financial Results

August 14, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for the three and six months ended June 30, 2012. Full financial statements and...

August 14, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen Reports Record 2Q12 revenues

August 14, 2012

WASHINGTON & MUMBAI, India--(BUSINESS WIRE)--Recognizing India as a model for the global vaccine market, BIO is pleased to announce programming to highlight this achievement at the 3rd Annual BIO India International Conference, September 12-...

August 14, 2012

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Altura Medical, Inc., an early stage medical device manufacturer, announced the appointment of G. Ray Martin, Ph.D. as Altura’s President and Chief Executive Officer and a member of the Board of Directors....

August 14, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--BioHorizons, a leading dental implant company, releases MinerOss Cancellous for dental bone grafting, expanding BioHorizons’ comprehensive offering of bone and soft tissue grafting products.

August 14, 2012

MOUNTAINSIDE, N.J.--(BUSINESS WIRE)--Proteonomix, Inc. (OTC/BB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that the U.S. Food and Drug Administration...

August 14, 2012

NEW YORK--(BUSINESS WIRE)--FertilityAuthority, the world's largest web portal for fertility information, has launched a new online patient scheduling service.

August 14, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that 77 percent of surveyed neurologists have experience with the STRATIFY JCVTM assay...

August 14, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--IMS Health today announced the acquisition of PharmaDeals Ltd., a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global...

August 14, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of Biopump™, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own...

August 14, 2012

MAPLE GROVE, Minn.--(BUSINESS WIRE)--UPSHER-SMITH COMPLETES ACQUISITION OF PROXIMAGEN GROUP PLC

August 14, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay, today announced that Robert Parson has joined the company’s management team as the Vice President of Regulatory and Clinical Affairs. Robert has 35 years of...

August 14, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for disposable anesthesia products

August 14, 2012

IRVINE, Calif. & LOUISVILLE, Colo.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB:CORX) and Pier Pharmaceuticals, Inc., a privately held biopharmaceutical company, announced they have consummated a merger under which Cortex and Pier...

August 14, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Atreca, Inc. has received exclusive license from Stanford University to immune repertoire capture technology that will accelerate discovery, development of novel therapeutic antibodies and vaccines.

August 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proteostasis Therapeutics announced that company scientists, founders and co-founders made several presentations at scientific conferences in the last month highlighting the company's recent progress.

August 14, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Top 10 drug makers have already invested significant manpower into digital marketing groups, averaging more than 23 FTEs dedicated to these new media activities, according to a new study.

August 14, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ:PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has finalized a reverse stock split. As previously announced in a news release dated...

August 14, 2012

PETALUMA, Calif.--(BUSINESS WIRE)--Tegal Corporation (NASDAQ: TGAL) today announced financial results for the First Quarter Fiscal Year 2013, which ended June 30, 2012. Fiscal 2013 First Quarter Financial Statement Highlights The Company’s Net...

August 14, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--McKesson Health Solutions announced that IDC Health Insights named it a “major player” in care management.

August 14, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--National Disability Institute (NDI) and Acorda Therapeutics announced they will launch a free six-part webinar series on financial, tax and investment topics for people living with multiple sclerosis (MS), their...

August 14, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, in partnership with the open-access publisher PLOS and open data repository figshare, announced today the launch of the Reproducibility Initiative (...

August 14, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NYSE MKT: PTX), a specialty pharmaceutical company, today announced financial results for the quarter and six months ended June 30, 2012....

August 14, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: An extraordinary general meeting of DiaGenic ASA (OSE:DIAG) was held on 14 August 2012. All proposals set out in the notice to the general meeting were approved. Please minutes from the...

August 14, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest reported on its FDA clinical guidance meeting that determined the U.S. registration pathway for BiovaxID, its personalized cancer vaccine for non-Hodgkin's lymphoma.

August 14, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals commences patient enrollment in the second part of randomized Phase 2 clinical program of ozarelix in men with prostate cancer for whom hormonal treatment is indicated.

August 14, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its support for The Joint Commission’s recent...

August 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today reported the financial results for...

August 14, 2012

AARHUS, Denmark--(BUSINESS WIRE)--Today CLC bio has introduced a reduced price of $79 for CLC Main Workbench for students. The license is a stand-alone license for a single computer and is valid for 12 months from the time of purchase. The $79...

August 13, 2012

WASHINGTON--(BUSINESS WIRE)--Press Kit Materials are Available at: http://www.tradeshownews.com/events/BIO...

August 13, 2012

MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2012. Kevin D. Clark, Chief Executive Officer, Chief Operating Officer...

August 13, 2012

WASHINGTON--(BUSINESS WIRE)--Press Kit Materials are Available at: http://www.tradeshownews.com/events/BIO...

August 13, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar Director Business Development Michael Sullivan to Co-Lead Pre-Conference Workshop at Marcus Evans 7th Annual Clinical Research in Emerging Countries Conference

August 13, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) reported financial results for the second quarter of fiscal 2012.